BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Genmab at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
Genmab takes part in 2 sessions at BIO-Europe 2026 in Cologne. Its sessions centre on partnering and business development, from dealmaking in a shifting global landscape to the next chapter for European biotech. One, shared with Ropes & Gray, traces the path from partnering pioneer to global biotech company.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
Genmab Copenhagen, Denmark | |
Danish biotech developing antibody therapeutics for cancer and other diseases. | Panel Mon Nov 9 13:00–14:00 Navigating partnering and business development in a shifting global landscape How funding conditions, treatment trends and geopolitics are shaping partnerships and acquisitions between drug and biotech companies, with real deal examples. Panel Tue Nov 10 10:45–11:15 From Partnering Pioneer to Global Biotech Leader: The Next Chapter for European Innovation How Genmab grew from licensing its discoveries to others into a global company selling its own drugs, and what European biotechs can learn. |
Find decision makers at Genmab
Tell us what you sell and we’ll find the people at Genmab most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction